Given the notable similarities in the effects of PDE10A inhibitors and D2 receptor antagonists across a range of experimental paradigms, why are only the latter compounds efficacious for ameliorating psychosis and delusions? The gene discussed is PDE10A; the disease is psychotic disorder.